|
|
|
|
Picture This: Molecular Maya Puts Life in Life Science Animations
Data Visualization Based on the Autodesk platform, Digizyme plug in proves aesthetic and educational effectiveness. By Kevin Davies January 10, 2012 | In 2010, a reporter sat in a Life
|
|
Cheminformatics in the Cloud
January 9, 2012 | Accelrys announced its next-generation informatics suite at its European user group meeting in Athens last year. The suite consists of some updated existing products and some new components, explains Accelrys’ senior director for life science marketing, Rob Brown. Those features include a chemical registration system, a chemical data cartridge, and a cloud-based product called HEOS, in partnership with SCYNEXIS, for externalizing research.
|
|
A QuantuMDx Leap for Handheld DNA Sequencing
Diagnostics From pharmacegenomic testing to handheld sequencing within 5 7 years? By Kevin Davies January 10, 2012 | MONTREAL—Speaking for the first time in his life as a commercial consultant rather than a public servant, Sir John Burn, a
|
|
The Unstable Equilibrium of the Bioinformatics Org Chart
By Aaron Kitzmiller January 10, 2012 | Inside the Box | In most organizations, the human resources of bioinformatics are a regular source of tension. Unless you’re particularly lucky, you can be plagued by politics, illogical decision making, disappointment, and
|
|
Products, Deployments, and News in Supercomputing
High Performance Computing The atmosphere at SC11 was big data focused and full of new tools. By Bio IT World Staff January 10, 2012 | SEATTLE—November’s Supercomputing 11
|
|
Notes from the Floor: SC11
Bio-IT World | This week’s Supercomputing 11 (SC11) conference in Seattle was full of news and product announcements across the industry, many of which featured companies active in life sciences. Here’s just a sampling of what caught Bio-IT World’s eye and ear.
|
|
PerkinElmer Targets Holistic Data Solutions
A series of acquisitions is expanding and refining the company’s focus, explains CSO Dan Marshak. November 15, 2011 | With its recent acquisitions of CambridgeSoft and Geospiza to name but two, PerkinElmer is signaling a new strategy that highlights data
|
|
Recent Sequencing Plans by the Numbers
Xconomy | What do 10,000 people with autism, 50,000 people in some remote islands in the North Atlantic, and 1,000 healthy old folks in southern California have in common?
|
|
Interpreting the Genome
By Kevin Davies September 27, 2011 | First Base | Twelve months ago, we published a special issue of Bio•IT World dedicated to “The Road to the $1,000 Genome.” While we didn’t expect to reach that momentous if somewhat arbitrary
|
|
Software Standards in Next-Gen Genomics
LIMS can help automate data transfer with sequencers. By Bruce Pharr September 27, 2011 | Guest Commentary | Standards are emerging in next generation sequencing (NGS), thanks mainly to the critical investments labs have made in instrumentation. Sequencing proceeds faster
|
Turning Genomics Data into Practical Insight With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can: - Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines.
- Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image).
Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands.
New Complimentary Market Survey… Collaborations and Communications Within Drug Discovery Research This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns. An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
Scientific Software Engineer
Boston MA
$70,000 to $95,000
Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET.
Apply at http://jobs.tessella.com
Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes. As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers. This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions. It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply
Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules. It is therefore suitable for use in a variety of markets including scientific research and clinical applications. As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team. The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market. This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company. Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial leadership, who wish to apply a fresh approach to existing markets. Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries. We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products. Click to Apply
|
|
|